tiprankstipranks
Trending News
More News >

New Portfolio - New Portfolio

Matan R

New Portfolio
Individual Investor
Ranked #589,389 out of 807,926 TipRanks' Investors
Success Rate
43%
27 out of 63
profitable transactions
Average Return
-9.87%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 7.96%
6-Month Return▲ 22.77%
12-Month Return▲ 1.22%
YTD Return▲ 29.69%
Total Return▼ 50.74%

Best Trade

Opened at
Closed at-
Gain▲ 288.35%

Bio

found them keep them

Performance

24.48%0-24.48%
▲ 5.10%
▼ 2.41%
▲ 3.03%
Dec 2024
▲ 6.03%
▲ 2.69%
▲ 11.28%
Jan 2025
▼ 12.86%
▼ 1.27%
▼ 2.23%
Feb 2025
▼ 1.80%
▼ 5.57%
▼ 6.33%
Mar 2025
▲ 1.84%
▼ 0.87%
▲ 1.67%
Apr 2025
▲ 12.20%
▲ 6.28%
▼ 1.29%
May 2025
▲ 6.24%
▲ 5.14%
▲ 24.48%
Jun 2025
▲ 12.57%
▲ 1.13%
▲ 1.87%
Jul 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 5.10%▼ 2.41%▲ 3.03%
▲ 6.03%▲ 2.69%▲ 11.28%
▼ 12.86%▼ 1.27%▼ 2.23%
▼ 1.80%▼ 5.57%▼ 6.33%
▲ 1.84%▼ 0.87%▲ 1.67%
▲ 12.20%▲ 6.28%▼ 1.29%
▲ 6.24%▲ 5.14%▲ 24.48%
▲ 12.57%▲ 1.13%▲ 1.87%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Chimerix
▲ 150.87%
5
Close
Apr 17, 2025
InterDigital
0%
▲ 7.28%
1
Open
Mar 11, 2025
VBI Vaccines
▼ 99.99%
6
Close
Jan 13, 2025
Bellerophon
▼ 73.84%
6
Close
Dec 18, 2024
G1 Therapeutics
▼ 67.28%
2
Close
Sep 17, 2024
Electrameccanica Vehicles
▼ 8.30%
6
Close
Mar 27, 2024
Xos
0.51%
▼ 66.90%
1
Open
Mar 27, 2024
Zynerba Pharmaceuticals
▼ 74.41%
2
Close
Oct 10, 2023
Playtika Holding
9.38%
▼ 49.22%
5
Open
Dec 22, 2021
Palantir Technologies
▲ 28.70%
3
Close
Dec 22, 2021
Alibaba
▼ 20.98%
3
Close
Sep 14, 2021
Cenntro Electric Group
▼ 44.05%
2
Close
Sep 13, 2021
Prothena
▲ 256.45%
2
Close
Jun 15, 2021
AYRO
0.54%
▼ 99.31%
1
Open
Mar 15, 2021
Perspective Therapeutics
7.3%
▲ 177.16%
2
Buy
Mar 05, 2021
Nano Dimension
11.61%
▼ 79.11%
1
Open
Mar 05, 2021
Gevo
16.76%
▼ 82.10%
3
Buy
Mar 05, 2021
Teva Pharmaceutical
▼ 0.09%
3
Close
Mar 02, 2021
Carisma Therapeutics
0.16%
▼ 97.67%
1
Open
Feb 05, 2021
Cue Biopharma
7.09%
▼ 95.34%
4
Buy
Feb 05, 2021